# New York Blood Center Enterprises - Inspection Records

Source: https://www.globalkeysolutions.net/companies/new-york-blood-center-enterprises/29bd2008-0b6c-4674-90f5-96ad1caea4db

> Inspection records and compliance data for New York Blood Center Enterprises in Long Island City, New York. Access full analysis and detailed observations.

---

## Details

- Name: New York Blood Center Enterprises
- FEI Number: 2473015
- City: Long Island City
- State: New York
- Country Name: United States
- Address Line 1: 4501 Vernon Blvd
- Zip Code: 11101

## Related Documents

- [483 - New York Blood Center Enterprises - Unknown Date](https://www.globalkeysolutions.net/records/483/new-york-blood-center-enterprises/eed1c575-459e-4f2d-b827-52aeb89623d1) — source: FDA, date: Invalid Date
- [FDA Inspection 1283668 - New York Blood Center Enterprises - 2025-09-24](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/91ecba89-ae8a-4854-a2eb-f3ceac565d66) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2025
- [FDA Inspection 1217513 - New York Blood Center Enterprises - 2023-09-07](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/c705a6ed-1f5c-44af-afd1-f42b0bc46779) — classification: No Action Indicated (NAI), source: FDA, date: September 7, 2023
- [FDA Inspection 1217513 - New York Blood Center Enterprises - 2023-09-07](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/47b41b89-58c5-4997-8124-42cebc55bddf) — classification: No Action Indicated (NAI), source: FDA, date: September 7, 2023
- [483 - New York Blood Center Enterprises - 2020-02-11](https://www.globalkeysolutions.net/records/483/new-york-blood-center-enterprises/3e5035ef-b0ef-43ea-b48b-39547a2005ad) — source: FDA, date: February 11, 2020
- [FDA Inspection 1118178 - New York Blood Center Enterprises - 2020-02-11](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/d7c05152-a755-44b7-acb6-8b9840cbb679) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 11, 2020
- [FDA Inspection 1036848 - New York Blood Center Enterprises - 2017-11-22](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/c5d0fa69-163e-462a-83c2-e34a55cd287b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2017
- [483 - New York Blood Center Enterprises - 2017-09-29](https://www.globalkeysolutions.net/records/483/new-york-blood-center-enterprises/89e4ed87-8aee-4226-bc00-c4c265fec5a4) — source: FDA, date: September 29, 2017
- [FDA Inspection 1027270 - New York Blood Center Enterprises - 2017-09-29](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/019b559d-7299-43c7-bebb-75f4f7aae907) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2017
- [FDA Inspection 945089 - New York Blood Center Enterprises - 2015-09-30](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/b0dbe26c-0ead-42e8-af81-3d11ba9acb49) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 30, 2015
- [FDA Inspection 824620 - New York Blood Center Enterprises - 2013-05-07](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/6eda6dfb-9267-4f31-82f8-6dabd55adb29) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 7, 2013
- [FDA Inspection 840106 - New York Blood Center Enterprises - 2013-04-08](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/3076d9f2-fb77-44d6-8014-414b9cc0d528) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 8, 2013
- [FDA Inspection 807056 - New York Blood Center Enterprises - 2012-11-15](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/39c368d3-99bc-41e9-86ad-2f9d85cb5c79) — classification: No Action Indicated (NAI), source: FDA, date: November 15, 2012

## Related Companies

- [Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany](https://www.globalkeysolutions.net/companies/halo-pharmaceutical-inc-dba-cambrex-whippany/1464443d-ae5a-4d06-959c-d1ccb1b213a2)
- [Cipla Limited](https://www.globalkeysolutions.net/companies/cipla-limited/ca77117b-0afe-4b51-bdc2-82ee1e242ec8)
- [Changzhou Pharmaceutical Factory](https://www.globalkeysolutions.net/companies/changzhou-pharmaceutical-factory/eea165e1-3df2-47c8-94b9-e8400af46bc4)
- [IDT Australia Ltd.](https://www.globalkeysolutions.net/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [Minaris Regenerative Medicine, LLC](https://www.globalkeysolutions.net/companies/minaris-regenerative-medicine-llc/b5fdb186-e2e7-416c-b89e-66d15dbf5509)
- [Hospira Zagreb d.o.o.](https://www.globalkeysolutions.net/companies/hospira-zagreb-doo/7c1e84f8-a21e-4e90-896a-ac33304219f1)
- [Norbrook Laboratories Limited](https://www.globalkeysolutions.net/companies/norbrook-laboratories-limited/c9294f28-e127-43a0-b824-82a6f41fabfd)
- [Genentech, Inc.](https://www.globalkeysolutions.net/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec)
- [Patheon Pharmaceuticals Inc.](https://www.globalkeysolutions.net/companies/patheon-pharmaceuticals-inc/f1ef6b53-3c20-4c22-9ef3-fd05fdb9f35b)
- [Shionogi Pharma Co., Ltd.](https://www.globalkeysolutions.net/companies/shionogi-pharma-co-ltd/bb3e5dcd-52f9-4971-9747-4c04b63ba0fa)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)
- [investigator](https://www.globalkeysolutions.net/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8)
- [Investigator](https://www.globalkeysolutions.net/people/burnell-m-henry/dece4407-3597-4a58-8756-5abf9db43bbc)